Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHow the switch works in practice, and what sets regulated suppliers apart
Step 1: Gather your current treatment evidence before you do anything else
The single most common hold-up when someone moves between Mounjaro suppliers is missing paperwork. Your new prescriber needs to see that your current dose was prescribed correctly and that you have been tolerating it. In practice that means having access to your most recent prescription or a record showing your dose, how long you have been on it, and ideally a recent weight reading.
If you are mid-titration (say, three weeks into a 10mg pen) tell the new service exactly that. A responsible prescriber will not simply issue the next dose up without evidence of where you are and that you have handled previous increases well. That is not bureaucracy for its own sake; it is the clinical check that keeps dose increases safe. Our Mounjaro overview explains how the titration schedule works from 2.5mg upward, which can help you frame your own history clearly.
One practical note on timing: if you are switching around a bank holiday or over Christmas, factor in that clinical review queues and delivery windows may shift slightly. Ordering before 12pm on the last working day before a break means your treatment is already dispatched rather than waiting for the other side of the holiday.
Step 2: Check that the new supplier is actually registered, and know why it matters
Tirzepatide sits on the MHRA's list of medicines that attract counterfeit activity. The regulator has issued repeated public warnings about fake weight-loss pens sold online, and enforcement operations in 2025 recovered around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million at street value. Some fake pens have contained insulin rather than the stated compound, with serious consequences for the people who used them.
Every legitimate UK pharmacy dispensing Mounjaro must be registered with the General Pharmaceutical Council. You can check any pharmacy's registration directly at the GPhC pharmacy register, just search by name or registration number. Suppliers who offer Mounjaro without a prescription, or at prices dramatically below the current market range, are a red flag. The MHRA encourages people to report suspect sellers through the Yellow Card scheme. A quick register check costs under a minute and is worth every second of it.
If you are currently comparing registered providers, our page on finding the best Mounjaro supplier in the UK walks through exactly what to look for beyond price.
Step 3: Understand what changes between suppliers, and what does not
Your tirzepatide is tirzepatide wherever it is dispensed legitimately: the same molecule, manufactured by Eli Lilly, supplied through the licensed UK supply chain. What varies between providers is the clinical infrastructure around the medicine, how consultations are conducted, how quickly prescriptions are reviewed, what aftercare looks like, and what the total price actually includes.
A comparison worth making before you switch is whether the headline price covers your prescription and consultation or adds those separately. Some services charge a consultation fee upfront and a prescription fee on top; others bundle everything. The Eli Lilly price increase from September 2025 pushed the list price of higher-dose pens considerably, and providers have priced accordingly, so what looked cheap six months ago may have changed. NICE's published guidance on tirzepatide (TA1026) is the clinical benchmark both NHS and private prescribers follow, and it is worth understanding the eligibility criteria it sets before assuming any provider will automatically continue your dose.
The table below summarises the main practical differences between the three main ways people currently access Mounjaro in the UK.
| Factor | NHS route (NICE TA1026) | Unverified online seller | Regulated private pharmacy (e.g. nume) |
|---|---|---|---|
| Prescription required? | Yes, via GP or specialist | Often issued without proper assessment | Yes, every order clinically reviewed |
| Eligibility criteria | Strict phased NHS thresholds (BMI ≥35+ comorbidities currently); NICE TA1026 | Not assessed | Private SmPC criteria (BMI ≥30, or ≥27 with a weight-related condition) |
| Waiting time | Often months to years | Immediate (no clinical review) | Same-day clinical review; next-day delivery if ordered before 12pm |
| Evidence of current dose required to continue? | Yes | Rarely | Yes, a prescriber reviews dose-increase evidence |
| Supply chain verified? | Yes (NHS procurement) | Unknown | Yes (licensed UK supply chain, Eli Lilly authorised) |
| Aftercare included? | Varies by service | None | 7-day priority aftercare included in price |
If you are also weighing up whether Mounjaro is the right medicine for you going forward, rather than simply moving it between providers, our weight-loss treatment overview sets out the licensed options available through nume and the clinical factors that distinguish them. And for people coming to Mounjaro from a different treatment entirely (such as Saxenda or orlistat) the process has a few extra steps; switching from Saxenda to Mounjaro covers what those involve. If you are thinking about moving to a newer option instead, our guides on switching from Mounjaro to retatrutide and on switching from a GLP-1 to tirzepatide walk through what each of those transitions involves clinically.
Which supplier best suits your situation, and whether your current dose should continue unchanged, is a clinical decision made with a prescriber who has seen your full picture. Our clinical team reviews every consultation personally. Start your free consultation to find out whether we are the right fit.
Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.